PATENT CLAIM ANALYSIS

Application Number: 15750595
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "230200"]

Abstract:
The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.

Claim (Index 37):
Crystalline Form-II of dolutegravir morpholine solvate, characterized by a powder X-Ray diffraction pattern having one or more peaks at about 6.78, 8.80, 11.56, 13.76, 14.80, 16.64, 17.56, 18.48, 19.34, 19.66, 20.40, 20.80, 21.48, 21.90, 22.74, 23.38, 25.24, 25.72, 27.56, 28.44, 29.54, 30.48 and 31.88\u00b10.2\u00b0 2\u03b8.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15533595', '14905062', '13001715', '14344737', '13027523']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818742328556743
- 35 USC 102 Novelty (BERT): 0.6035594303955204
- Combined Prediction Score: 0.7972240387406208
- Mean Citation Score: 415.504956
- Max Citation Score: 549.39343
- Similarity Product: 471.23180044131095

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test